JAC Advance Access originally published online on September 2, 2005
Journal of Antimicrobial Chemotherapy 2005 56(4):794-795; doi:10.1093/jac/dki316
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Loss of mecA gene in Staphylococcus epidermidis after prolonged therapy with vancomycin
Division of Infectious Diseases, Basel University Medical Clinic, Rheinstrasse 26, CH-4410 Liestal, Switzerland
* Corresponding author. Tel: +41-61-925-34-19; Fax: +41-61-925-28-04; E-mail: sendi-pa@magnet.ch
Keywords: methicillin resistance , S. epidermidis , gene loss , glycopeptides
| The first 10% of the full text of this article appears below. |
Sir,
The most commonly cultured microorganisms in prosthetic-joint infections are coagulase-negative staphylococci.1 Resistance to ß-lactam antibiotics is encoded by the mecA gene; this gene is carried on a mobile genetic element, the staphylococcal chromosome cassette mec (SCCmec). Loss or deletion of the mecA gene rarely occurs, mainly due to factors affecting the stability of SCCmec. Vancomycin may
Transparency declarations